Ki-67 Antigen

"Ki-67 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.

Descriptor ID	D019394
MeSH Number(s)	D12.776.660.625.500 D23.050.290.500 D23.101.140.400
Concept/Terms	Ki-67 Antigen Ki-67 Antigen Antigen, Ki-67 Ki 67 Antigen Antigen Ki-67 Antigen Ki 67 Ki-67, Antigen MIB-1 Antigen Antigen, MIB-1 MIB 1 Antigen MIB-1 Protein MIB 1 Protein Antigen Ki67 Ki67, Antigen

Below are MeSH descriptors whose meaning is more general than "Ki-67 Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Nuclear Proteins [D12.776.660]
Antigens, Nuclear [D12.776.660.625]
Ki-67 Antigen [D12.776.660.625.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Nuclear [D23.050.290]
Ki-67 Antigen [D23.050.290.500]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]
Ki-67 Antigen [D23.101.140.400]

Below are MeSH descriptors whose meaning is more specific than "Ki-67 Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ki-67 Antigen" by people in this website by year, and whether "Ki-67 Antigen" was a major or minor topic of these publications.

Bar chart showing 19 publications over 10 distinct years, with a maximum of 5 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	2	2
2004	0	1	1
2006	0	2	2
2008	0	1	1
2011	0	1	1
2012	1	2	3
2013	1	4	5
2014	0	1	1
2016	1	0	1
2017	0	2	2

Below are the most recent publications written about "Ki-67 Antigen" by people in Profiles.

Jayaraman S, Pazhani J, PriyaVeeraraghavan V, Raj AT, Somasundaram DB, Patil S. PCNA and Ki67: Prognostic proliferation markers for oral cancer. Oral Oncol. 2022 Jul; 130:105943.

View in: PubMed
Bundred N, Porta N, Brunt AM, Cramer A, Hanby A, Shaaban AM, Rakha EA, Armstrong A, Cutress RI, Dodwell D, Emson MA, Evans A, Hartup SM, Horgan K, Miller SE, McIntosh SA, Morden JP, Naik J, Narayanan S, Ooi J, Skene AI, Cameron DA, Bliss JM. Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clin Cancer Res. 2022 Apr 01; 28(7):1323-1334.

View in: PubMed
Shikdar S, Hall S, Taylor B, de Los Angeles J, Tahirkheli M, Zhao D, Razaq W. Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer. Oncology. 2022; 100(6):337-343.

View in: PubMed
Tibrewal M, Cheng B, Dohare P, Hu F, Mehdizadeh R, Wang P, Zheng D, Ungvari Z, Ballabh P. Disruption of Interneuron Neurogenesis in Premature Newborns and Reversal with Estrogen Treatment. J Neurosci. 2018 01 31; 38(5):1100-1113.

View in: PubMed
Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, Gordon LK, Wadehra M, Yang I. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathol. 2018 Jan; 35(1):1-9.

View in: PubMed
Zaidi HA, Cote DJ, Dunn IF, Laws ER. Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci. 2016 Dec; 34:246-251.

View in: PubMed
Myers DA, Singleton K, Hyatt K, Mlynarczyk M, Kaushal KM, Ducsay CA. Long-Term Gestational Hypoxia Modulates Expression of Key Genes Governing Mitochondrial Function in the Perirenal Adipose of the Late Gestation Sheep Fetus. Reprod Sci. 2015 Jun; 22(6):654-63.

View in: PubMed
Yadav VR, Sahoo K, Awasthi V. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. Br J Pharmacol. 2013 Dec; 170(7):1436-48.

View in: PubMed
McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol. 2013 Nov; 37(11):1671-7.

View in: PubMed
Hurst RE, Hauser PJ, Kyker KD, Heinlen JE, Hodde JP, Hiles MC, Kosanke SD, Dozmorov M, Ihnat MA. Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy". PLoS One. 2013; 8(5):e64181.

View in: PubMed

People

Explore

Similar Concepts

Top Journals